Opinion statement
One of the most common beliefs in the management of Crohn’s disease is that surgery should be considered only as a last resort. Surgery is often considered by patients and gastroenterologists to represent a "failure." However, the role of surgery in the care of patients with Crohn’s disease has increasingly become a collaborative effort, with surgeons involved in many aspects of the management of these patients. This is particularly true in pediatric patients, as issues of growth and development may involve surgical intervention at earlier stages than might be required in older patients. In fact, surgical interventions may be indicated at any stage of the disease process. For example, early examination under anesthesia with abscess drainage and delineation of fistula tracts has proven very useful in patients with complex perineal disease. Surgery may contribute to the medical management of the disease by way of providing chronic enteral or parenteral access for nutritional interventions such as elemental feedings and total parenteral nutrition. Finally, surgical treatment of intraabdominal complications including fistulas, phlegmon, and bowel strictures may have a dramatic impact on patient symptoms and side effects. Although bowel resection carries the long-term risk of short bowel syndrome should future resections be required, the improvements in medical therapy continue to reduce the risk of recurrent disease, making surgical resection more palatable. Surgical treatment of complicated disease offers significant potential to limit toxic medical therapy and improve quality of life. In addition, application of minimally invasive techniques can minimize the impact of insults to body image in this vulnerable patient population as well as speed recovery. Future interventions may be facilitated by reducing adhesion formation through the use of minimally invasive techniques. The dynamic nature of growth and development in the pediatric population presents unique complications from medical therapies that are different from those seen in adults. Criteria for surgical intervention must be interpreted in light of the specific challenges facing the pediatric population as frequently pointed out in the oft-quoted maxim, "children are not small adults!"
Similar content being viewed by others
References and Recommended Reading
Aufsus AH: The history of surgery for Crohn’s disease at the Mount Sinai Hospital. Mt Sinai J Med 2000, 67: 198–203.
Garlock JH, Crohn BB: Appraisal of results of surgery in the treatment of regional enteritis. J Am Med Ass 1945, 127: 205–208.
Greenstein AJ, Sachar D, Pucillo A, et al.: Cancer in Crohn’s disease after divisionary surgery. A report of seven carcinomas occurring in excluded bowel. Am J Surg 1978, 135: 86–90.
von Allmen D, Markowitz JE, York A, et al.: Laparoscopic-assisted bowel resection offers advantages over open surgery for treatment of segmental Crohn’s disease in children. J Pediatr Surg 2003, 38: 963–965.
Regueiro M, Mardini H: Treatment of perianal fistulizing Crohn’s disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm Bowel Dis 2003, 9: 98–103.
Batres SA, Ng LA, Baldassano R: Growth failure in the child with inflammatory bowel disease. Semin Gastrointest Dis 2001, 12: 253–262.
Rabbett H, Elbadri A, Thwaites R, et al.: Quality of life in children with Crohn’s disease. J Pediatr Gastroenterol Nutr 1996, 23: 528–533.
Akobeng AK, Suresh-Babu MV, Firth D, et al.: Quality of life in children with Crohn’s disease: a pilot study. J Pediatr Gastroenterol Nutr 1999, 28: S37-S39.
Rintala RJ, Lindahl HG: Proctocolectomy and J-pouch ileo-anal anastomosis in children. J Pediatr Surg 2002, 37: 66–70.
Su FW, Beckman DB, Yarnold PA, Grammer LC: Low incidence of complications in asthmatic patients treated with preoperative corticosteroids. Allergy Asthma Proc 2004, 25: 327–333.
Kennedy ED, Urbach DR, Krahn MD, et al.: Azathioprine or ileocolic resection for steroid-dependent terminal ileal Crohn’s disease? A Markov analysis. Dis Colon Rectum 2004, 47: 2120–2130.
Cosnes J, Nion-Larmurier I, Beaugerie L, et al.: Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery. Gut 2005, 54: 237–241.
Ardizzone S, Maconi G, Sampietro GM, et al.: Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn’s disease. Gastroenterology 2004, 127: 990–993.
Sandborn WJ, Feagan BG: The efficacy of azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in patients with Crohn’s disease remains uncertain. Gastroenterology 2004, 127: 990–993.
Rutgeerts P: Strategies in the prevention of post-operative recurrence in Crohn’s disease. Best Pract Res Clin Gastroenterol 2003, 17: 63–73.
Sandborn WJ, Fazio VW, Feagan BG: American Gastroenterological Association Clinical Practice Committee. AGA technical review on perianal Crohn’s disease. Gastroenterology 2003, 125: 1508–1530. A comprehensive review of the anatomy and treatment options for perianal Crohn’s disease.
Judge TA, Lichtenstein GR: Treatment of fistulizing Crohn’s disease. Gastroenterol Clin North Am 2004, 33: 421–454.
Topstad DR, Panaccione R, Heine JA, et al.: Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn’s disease: a single center experience. Dis Colon Rectum 2003, 46: 577–583.
Regueiro M, Mardini H: Treatment of perianal fistulizing Crohn’s disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm Bowel Dis 2003, 9: 98–103.
Poritz LS, Rowe WA, Koltun WA: Remicade does not abolish the need for surgery in fistulizing Crohn’s disease. Dis Colon Rectum 2002, 45: 771–775.
Marchal L, D’Haens G, Van Assche G, et al.: The risk of post-operative complications associated with infliximab therapy for Crohn’s disease: a controlled cohort study. Aliment Pharmacol Ther 2004, 19: 749–754.
Colombel JF, Loftus EV Jr, Tremaine WJ, et al.: Early postoperative complications are not increased in patients with Crohn’s disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 2004, 99: 878–883.
Friesen CA, Calabro C, Christenson K, et al.: Safety of infliximab treatment in pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2004, 39: 265–269.
Tersigni R, Alessandroni L, Barreca M, Piovanello P: Does stapled functional end-to-end anastomosis affect recurrence of Crohn’s disease after ileocolonic resection? Hepatogastroenterology 2003, 50: 1422–1425.
Munoz-Juarez M, Yamamoto T, Wolff BG, Keighley MR: Wide-lumen stapled anastomosis vs. conventional end-to-end anastomosis in the treatment of Crohn’s disease. Dis Colon Rectum 2001, 44: 20–25.
Ikeuchi H, Kusunoki M, Yamamura T: Long-term results of stapled and hand-sewn anastomoses in patients with Crohn’s disease. Dig Surg 2000, 17: 493–496.
Resegotti A, Astegiano M, Farina EC, et al.: Side-to-side stapled anastomosis strongly reduces anastomotic leak rates in Crohn’s disease surgery. Dis Colon Rectum 2005, 48: 464–468.
Dutta S, Rothenberg SS, Chang J, Bealer J: Total intracorporeal laparoscopic resection of Crohn’s disease. J Pediatr Surg 2003, 38: 717–719.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
von Allmen, D. Surgical management of crohn’s disease in children. Curr Treat Options Gastro 8, 405–410 (2005). https://doi.org/10.1007/s11938-005-0043-7
Issue Date:
DOI: https://doi.org/10.1007/s11938-005-0043-7